<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01507363</url>
  </required_header>
  <id_info>
    <org_study_id>THL-06-11</org_study_id>
    <secondary_id>2011-003105-22</secondary_id>
    <secondary_id>H-4-2011-082</secondary_id>
    <nct_id>NCT01507363</nct_id>
  </id_info>
  <brief_title>Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)</brief_title>
  <official_title>Analgesic Effect of Perioperative Gabapentin in Total Knee Arthroplasty: A Randomized, Double-blind, Placebo-controlled, Dose-response Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lundbeck Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain is a major problem after TKA. Gabapentin may reduce acute postoperative pain. The
      investigators therefore investigate the effect of Gabapentin as a perioperative analgesic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain is a major problem after TKA. Studies indicate that Gabapentin may reduce acute
      postoperative pain. However, the optimal dose is unknown and there is constant controversy on
      analgesic versus side-effects. The investigators therefore investigate the effect of
      Gabapentin as a perioperative analgesic in a dose-related manner and with a sample-size
      allowing evaluation of side-effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>At 24 hour</time_frame>
    <description>Pain during walking at 24 hour after surgery, visuel analog scale (VAS, 0-100 mm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>At 6 hours</time_frame>
    <description>Sedation at 6 hours, numeric range scale (NRS, 0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>1 week</time_frame>
    <description>Pain at rest and during walking the first week after TKA, visuel analog scale (VAS, 0-100 mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulated pain scores</measure>
    <time_frame>1 week</time_frame>
    <description>Cumulated pain scores for pain the first week after TKA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of rescue analgesic</measure>
    <time_frame>1 week</time_frame>
    <description>Amount of rescue analgesic the first week after TKA, mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>1 week</time_frame>
    <description>Side effects the first week after TKA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulated side effects scores</measure>
    <time_frame>1 week</time_frame>
    <description>Cumulated side effects scores the first week after TKA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of ondansetron and sleeping medicine</measure>
    <time_frame>1 week</time_frame>
    <description>Amount of ondansetron and sleeping medicine the first week after TKA, mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>1 week</time_frame>
    <description>Anxiety and depression - questionnaire - the first week after TKA, Hospitality and Anxiety and Depression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gabapentin level in blood-sample</measure>
    <time_frame>1 Day</time_frame>
    <description>Gabapentin level in blood-sample at 12 am on the first day after surgery, serum-koncentration</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Sedation</condition>
  <arm_group>
    <arm_group_label>Gabapentin &quot;high&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tables with Gabapentin (1300 mg/day) for 7 days, starting on the day of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gabapentin &quot;intermediate&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tables with Gabapentin for 7 days (900 mg/day), starting on the day of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablets for 7 days, starting on the day of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Tables with Gabapentin (1300 mg/ day) for 7 days, starting on the day of surgery</description>
    <arm_group_label>Gabapentin &quot;high&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Tables with Gabapentin (900 mg/day) for 7 days, starting on the day of surgery</description>
    <arm_group_label>Gabapentin &quot;intermediate&quot;</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablets for 7 days, starting on the day of surgery</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary, unilateral total knee arthroplasty (TKA)

          -  Age 50-85 years

          -  Ethnic Danes

        Exclusion Criteria:

          -  Treatment with gabapentins, systemic glucocorticoids, opioids, anxiolytic agents,
             antiepileptics or antidepressive agents (last 4 weeks)

          -  History of depression or mania

          -  History of alcohol or drug abuse

          -  History of malignancy

          -  History of epilepsia

          -  BMI &gt; 40

          -  Disease affecting central or peripheral nerve function

          -  History of dementia

          -  History of renal insufficiency

          -  Allergy to Gabapentin

          -  Women with menstruation (last 2 years)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torben B Hansen B Hansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regionshospitalet Holstebro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Kehlet, MD</last_name>
    <role>Study Director</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jørgen B Dahl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Per W Kristensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vejle Sygehus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Husted, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hvidovre University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Søren Solgaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gentofte Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mogens B Laursen, MD, Phd.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg Sygehus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lars Hansen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Esbjerg Sygehus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dep. of anesthesiology and ortopedic surgery Hvidovre Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Hvidovre</state>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dep. of ortopedic surgery, Aalborg Sygehus</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dep. of ortopedic surgery, Esbjerg Sygehus</name>
      <address>
        <city>Esbjerg</city>
        <zip>6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 6, 2012</study_first_submitted>
  <study_first_submitted_qc>January 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2012</study_first_posted>
  <last_update_submitted>April 10, 2014</last_update_submitted>
  <last_update_submitted_qc>April 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Troels Haxholdt Lunn</investigator_full_name>
    <investigator_title>MD, principal and koordinating investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

